Hidden stomach germs found during routine colonoscopy in healthy adults
NCT ID NCT07346521
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at how common Helicobacter pylori (a stomach germ linked to cancer) is in adults without stomach symptoms who are already getting a screening colonoscopy. About 1,000 participants will also have a stomach exam (gastroscopy) during the same visit, with small tissue samples taken to check for the germ and early cancer signs. The goal is to learn how often these hidden risks occur and if they are linked to lifestyle or family history.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 1,000 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Dec 2025
- Expected to finish
-
Dec 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Asymptomatic patients without upper gastrointestinal symptoms undergoing a Screening-Colonoscopy
- Ages
-
30 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Age ≥ 30 years * Scheduled screening colonoscopy (either initial screening or surveillance following previously detected polyps) * Asymptomatic (no gastrointestinal symptoms) * Willingness and consent to undergo simultaneous gastroscopy with biopsy sampling * Written informed consent to participate in the study, including the use of histological findings and patient data for study analysis Exclusion Criteria: * Known Helicobacter pylori infection or previous treatment for H. pylori * Current or recent proton pump inhibitor (PPI) therapy (\< 4 weeks) * Pre-existing gastrointestinal diseases (e.g., chronic gastritis, ulcer, gastric carcinoma) * Immunosuppression or relevant underlying diseases * Refusal to undergo additional gastroscopy or biopsy
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Barett's esophagus are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Wiener Privatklinik (WPK)
RECRUITINGVienna, 1090, Austria
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Stomach biopsies could reveal Antibiotic-Resistant h. pylori without extra tests
- Can a Two-Drug combo beat a stubborn stomach bug?
- A simple test could spot who will develop stomach cancer
- A 10-Day h. pylori cure? new trial tests a streamlined approach
- Stomach bug tied to belly fat and blood sugar issues?
- New acid reducer shows promise in fighting stomach bug